Literature DB >> 3282084

Human immunodeficiency virus test evaluation, performance, and use. Proposals to make good tests better.

J S Schwartz1, P E Dans, B P Kinosian.   

Abstract

Human immunodeficiency virus (HIV) tests are essential for detecting asymptomatic infection and are helpful in confirming the diagnoses of acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Nonetheless, many aspects of their use remain controversial, partly because of concerns about test accuracy. This article reviews the scientific basis for the evaluation, performance, and use of the most commonly employed HIV assays. Current test performance could be improved by better standardization of test procedures and institution of mandatory proficiency testing and licensure of clinical laboratories that perform HIV testing. Test utility could be enhanced by sequencing tests more appropriately and by interpreting test results in conjunction with the clinical purpose for which the test is being used and the characteristics of the population under study. Finally, HIV tests should be evaluated in a manner that minimizes spectrum and referral bias and inadequate reference standard confirmation, problems that have affected the evaluation of current tests.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  1988        PMID: 3282084

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Indeterminate HIV-1 western blots: implications and considerations for widespread HIV testing.

Authors:  C L Celum; R W Coombs
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

2.  Peter Emanuel Dans, MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Peter Emanuel Dans
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-01

3.  Indirect immunofluorescence test performance and questionnaire results from the Centers for Disease Control Model Performance Evaluation Program for human immunodeficiency virus type 1 testing.

Authors:  R N Taylor; T L Hearn; W O Schalla; R O Valdiserri
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Impact of proficiency testing program for laboratories conducting early diagnosis of HIV-1 infection in infants in low- to middle-income countries.

Authors:  Albert Garcia; Shambavi Subbarao; Guoqing Zhang; Linda Parsons; John Nkengasong; Chin-Yih Ou; Dennis Ellenberger
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

5.  Evaluation of Chiron HIV-1/HIV-2 recombinant immunoblot assay.

Authors:  R L Kline; D McNairn; M Holodniy; L Mole; D Margolis; W Blattner; T C Quinn
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

6.  HIV antibody testing in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1993-03-01       Impact factor: 8.262

Review 7.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

8.  Utility of quantitative enzyme immunoassay reactivity for predicting human immunodeficiency virus seropositivity in low- and high-prevalence populations.

Authors:  X Hou; P L Breese; J M Douglas
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Evaluation of the Genetic Systems Corp. Integra HIV-1 Pageblot system.

Authors:  C A Starkey; B Yen-Lieberman; M R Proffitt
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

10.  Multicentre study for diagnostic evaluation of an assay for simultaneous detection of antibodies to HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0).

Authors:  P Bachmann; J Beyer; S Brust; W Engelhardt; L G Gürtler; K O Habermehl; A Karakassopoulos; U Michl; A Mühlbacher; M Stöffler-Meilicke
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.